Patents by Inventor Mary WOODALL-JAPPE

Mary WOODALL-JAPPE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11707448
    Abstract: The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: July 25, 2023
    Assignee: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Xingfeng Bao, Diana Albu, Mary Woodall-Jappe
  • Publication number: 20220071959
    Abstract: The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Inventors: Xingfeng BAO, Diana ALBU, Mary WOODALL-JAPPE
  • Publication number: 20220062390
    Abstract: One aspect of the technology described herein relates to a method for treating a subject having a cancer. This method involves selecting a subject having cancer; administering, to the selected subject, a cytotoxic fusion protein comprising an N-terminus coupled to a C-terminus, wherein the N-terminus comprises diphtheria toxin fragments A and B and the C-terminus comprises human IL-2; and administering, to the selected subject, a programmed cell death-1 receptor (PD-1) pathway inhibitor to treat the cancer in the subject. Also disclosed is a method for sensitizing a target cell population to treatment with a PD-1 pathway inhibitor, as well as compositions and kits for use in treating a subject having cancer.
    Type: Application
    Filed: August 23, 2021
    Publication date: March 3, 2022
    Applicant: Dr. Reddy's Laboratories SA
    Inventors: Anil Namboodiripad, A. Raghav Chari, Chandrasekhar Goda, Mary Woodall-Jappe, Preeti Singh
  • Publication number: 20170182003
    Abstract: The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.
    Type: Application
    Filed: May 21, 2015
    Publication date: June 29, 2017
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Xingfeng BAO, Diana ALBU, Mary WOODALL-JAPPE